• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Schott Pharma launches pre-filled polymer syringes for deep-cold drugs

May 17, 2023 By Sean Whooley

Schott Pharma Toppac Freeze pre-filled syringe
The Toppac Freeze pre-filled syringe. [Image courtesy of Schott Pharma]
Schott Pharma announced today that it launched pre-fillable syringes made from advanced polymers for delivering deep-cold drugs.

These deep-cold drugs are stored and transported on dry ice at temperatures reaching -100°C. Schott designed the syringes from an advanced, pharmaceutical-grade polymer, delivered in a standardized nest and tub configuration. This ensures compatibility on major fill-finish lines to simplify the filling process.

Drug manufacturers can benefit from an extensive scientific data package developed by Schott. It details the 1 mL-long syringes’ performance at deep-cold temperatures. These syringes also raise the bar on quality, Schott said, with best-in-class specification and a fast-track supply process.

“While pre-fillable syringes are typically favored for drug delivery due to their speed and convenience, they were not a viable option for drugs that require storage at -100°C. But now, for the first time, deep-cold medications can be introduced to the market using pre-fillable polymer syringes,” said Andreas Reisse, CEO of Schott Pharma. “The drug development pipeline for these drugs is extensive, including various therapies such as mRNA, cell, and gene therapies.”

More about the Schott Pharma pre-filled syringes

Schott said deep-cold medications require delivery systems capable of withstanding harsh conditions. The company’s polymer syringes protect the drugs even at temperatures approaching -100°C while maintaining syringe functionality.

“Our polymer syringes are a favorable choice for deep-cold drugs thanks to the entire platform system, which includes the polymer material, siliconization, the plunger material, and the overall quality management system, among others,” explains Mario Haas, head of drug delivery systems at Schott Pharma. “Based on our track record in the field of mRNA-based applications, we are ready to bring the next deep-cold drugs to the market together with our customers.”

Schott built its drug delivery system, called Toppac freeze, from cyclic olefin copolymer (COC). The break-resistant, biologically inert material features advanced barrier properties to ensure drug stability. Its scientific data package features data on container closure integrity, functionality and particulate generation after freeze and thaw cycles.

“Our state-of-the-art manufacturing process is designed to achieve consistently high quality,” said Haas. “Combined with enhanced quality control of all critical to quality (CtQ) syringe attributes, we can ensure that each polymer syringe fulfills the high requirements needed for deep-cold applications.”

Filed Under: Drug-Device Combinations, Featured, Pharmaceuticals Tagged With: Schott Pharma

IN CASE YOU MISSED IT

  • Medtronic unveils “MiniMed” as name for soon-to-be separated Diabetes unit
  • Insulet, Marvel collab to unveil comic book hero with type 1 diabetes
  • Insulet rolls out new Omnipod 5 iPhone app for use with Dexcom G7
  • Tandem, Abbott strike deal to pair insulin pumps with glucose-ketone monitor
  • Mosanna launches with $80M to support nasal spray for obstructive sleep apnea

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at swhooley@wtwhmedia.com.

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS